MXCT Company Profile and Key Details

Q: Who are the executives of MXCT?

Mr. James LovgrenSenior Vice President of Global MarketingMr. Thomas Michael RossExecutive Vice President of Global Sales & MarketingDr. Cenk SumenChief Scientific OfficerMr. Ronald Evan Holtz CPA, Ph.D.Executive Vice President of Admin.Mr. Douglas Arthur DoerflerFounder, Pres, Chief Executive Officer & Executive DirectorDr. Cenk Sumen Ph.D.Chief Scientific OfficerMr. Maher MasoudExecutive Vice President, Gen. Counsel & Sec.Mr. Douglas J. Swirsky CFA, CPAChief Financial OfficerMr. Sean MenarguezDirector of Investor RelationsDr. J. Stark Thompson Ph.D.ConsultantDr. James Brady Ph.D.Senior Vice President of Technical Applications & Customer SupportDr. Sarah Haecker Meeks Ph.D.Senior Vice President of Bus. Devel.

NASDAQ : MXCT

MaxCyte

$1.19

-0.03-2.46%

At Close 4:00 PM

75.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MaxCyte, Inc. (MXCT) stock declined over -2.46%, trading at $1.19 on NASDAQ, down from the previous close of $1.22. The stock opened at $1.22, fluctuating between $1.18 and $1.22 in the recent session.

Stock Snapshot

1.22

Prev. Close

127.47M

Market Cap

1.18

Day Low

-3.97

P/E Ratio

-0.3

EPS (TTM)

-0.24

Cash Flow per Share

1.22

Open

107.12M

Number of Shares

1.22

Day High

90.22%

Free Float in %

2.24

Book Value

300.46K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	1.22	1.23	1.18	1.19	300.46K
Sep 09, 2026	1.29	1.29	1.22	1.22	393.99K
Sep 08, 2026	1.29	1.29	1.25	1.27	432.86K
Sep 04, 2026	1.25	1.30	1.25	1.28	333.51K
Sep 03, 2026	1.27	1.27	1.22	1.26	425.93K
Sep 02, 2026	1.24	1.31	1.22	1.27	502.31K
Sep 01, 2026	1.26	1.28	1.22	1.24	678.89K
Aug 31, 2026	1.19	1.32	1.19	1.29	777.28K
Aug 28, 2026	1.30	1.30	1.21	1.22	563.09K
Aug 27, 2026	1.31	1.33	1.28	1.28	360.04K
Aug 26, 2026	1.35	1.35	1.31	1.31	291.91K
Aug 25, 2026	1.38	1.39	1.34	1.35	310.49K
Aug 24, 2026	1.36	1.40	1.35	1.39	619.49K
Aug 21, 2026	1.40	1.40	1.36	1.38	435.8K
Aug 20, 2026	1.39	1.41	1.36	1.38	608.14K
Aug 19, 2026	1.29	1.40	1.27	1.39	948.34K
Aug 18, 2026	1.30	1.31	1.26	1.27	443.4K
Aug 17, 2026	1.32	1.39	1.30	1.32	703.24K
Aug 14, 2026	1.39	1.41	1.27	1.32	1M
Aug 13, 2026	1.17	1.54	1.16	1.39	3.8M

Contact Details

Rockville, MD 20850

United States

https://www.maxcyte.com 301 944 1700

About Company

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Frequently Asked Questions

What is the current MaxCyte, Inc. (MXCT) stock price?

MaxCyte, Inc. (NASDAQ: MXCT) stock price is $1.19 in the last trading session. During the trading session, MXCT stock reached the peak price of $1.22 while $1.18 was the lowest point it dropped to. The percentage change in MXCT stock occurred in the recent session was -2.46% while the dollar amount for the price change in MXCT stock was - $0.03.

MXCT's industry and sector of operation?

The NASDAQ listed MXCT is part of Biotechnology industry that operates in the broader Healthcare sector. MaxCyte, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MXCT?

Mr. James Lovgren
Senior Vice President of Global Marketing
Mr. Thomas Michael Ross
Executive Vice President of Global Sales & Marketing
Dr. Cenk Sumen
Chief Scientific Officer
Mr. Ronald Evan Holtz CPA, Ph.D.
Executive Vice President of Admin.
Mr. Douglas Arthur Doerfler
Founder, Pres, Chief Executive Officer & Executive Director
Dr. Cenk Sumen Ph.D.
Chief Scientific Officer
Mr. Maher Masoud
Executive Vice President, Gen. Counsel & Sec.
Mr. Douglas J. Swirsky CFA, CPA
Chief Financial Officer
Mr. Sean Menarguez
Director of Investor Relations
Dr. J. Stark Thompson Ph.D.
Consultant
Dr. James Brady Ph.D.
Senior Vice President of Technical Applications & Customer Support
Dr. Sarah Haecker Meeks Ph.D.
Senior Vice President of Bus. Devel.

How MXCT did perform over past 52-week?

MXCT's closing price is 85.07% higher than its 52-week low of $0.64 where as its distance from 52-week high of $1.87 is -36.19%.

How many employees does MXCT have?

Number of MXCT employees currently stands at 91.

Link for MXCT official website?

Official Website of MXCT is: https://www.maxcyte.com

How do I contact MXCT?

MXCT could be contacted at phone 301 944 1700 and can also be accessed through its website. MXCT operates from 9713 Key West Avenue, Rockville, MD 20850, United States.

How many shares of MXCT are traded daily?

MXCT stock volume for the day was 300.46K shares. The average number of MXCT shares traded daily for last 3 months was 1.08M.

What is the market cap of MXCT currently?

The market value of MXCT currently stands at $127.47M with its latest stock price at $1.19 and 107.12M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	91
Beta	1.49
Sales or Revenue	$41.29M
5Y Sales Change%	0.228%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	91
Beta	1.49
Sales or Revenue	$41.29M
5Y Sales Change%	0.228%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MXCT Company Profile and Key Details

MaxCyte

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways